Gain Therapeutics Inc (GANX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 0 | 55k | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M | -4.46M |
| Pre Tax Income | -4.6M | -5.12M | -7.66M | -4.7M | -4.71M | -3.99M | -8.14M | -4.48M |
| Net Income | -4.68M | -5.14M | -7.69M | -4.72M | -4.57M | -4.01M | -8.14M | -4.49M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M | -4.46M |
| EBITDA | -4.54M | -5.21M | -7.71M | -4.86M | -4.38M | -4.36M | -8.16M | -4.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41k | 29k | 196k | 140k | 55k |
| Operating Income | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
| Pre Tax Income | -2.19M | -3.57M | -13.86M | -17.5M | -22.19M |
| Net Income | -2.19M | -3.58M | -13.86M | -17.59M | -22.11M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.975 | -0.889 | -1.166 | -1.48 | -1.713 |
| EBIT | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
| EBITDA | -2.1M | -3.47M | -13.78M | -17.71M | -22.17M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
